Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00973375
Recruitment Status : Unknown
Verified September 2009 by Liuhuaqiao Hospital.
Recruitment status was:  Recruiting
First Posted : September 9, 2009
Last Update Posted : September 9, 2009
Sponsor:
Information provided by:
Liuhuaqiao Hospital

Tracking Information
First Submitted Date September 8, 2009
First Posted Date September 9, 2009
Last Update Posted Date September 9, 2009
Study Start Date May 2009
Primary Completion Date Not Provided
Current Primary Outcome Measures
 (submitted: September 8, 2009)
Segment and instent restenosis measured by coronary angiography and IVUS. [ Time Frame: at 12 months after implantation ]
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures
 (submitted: September 8, 2009)
Uncovered and malposition of stent. [ Time Frame: at 12 months after implantation. ]
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals
Official Title Not Provided
Brief Summary The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Control
Time Perspective: Cross-Sectional
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.
Condition Drug Eluting Stent
Intervention Not Provided
Study Groups/Cohorts Endeavor group and Excel group
Endeavor group: measurements from the vessels implanted Endeavor stent(s). Excel group: measurements from the vessels implanted Excel stent(s).
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: September 8, 2009)
30
Original Estimated Enrollment Same as current
Study Completion Date Not Provided
Primary Completion Date Not Provided
Eligibility Criteria

Inclusion Criteria:

  • These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Exclusion Criteria:

  • Dual anti-platelet therapy less than 12 months.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 75 Years   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries China
Removed Location Countries  
 
Administrative Information
NCT Number NCT00973375
Other Study ID Numbers LHQ09-003
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Dingcheng Xiang, MD., Ph.D, Liuhuaqiao Hospital
Study Sponsor Liuhuaqiao Hospital
Collaborators Not Provided
Investigators Not Provided
PRS Account Liuhuaqiao Hospital
Verification Date September 2009